SCHEMBL2448406

SCHEMBL2448406

O=C(Nc1ccc2ccccc2c1)c1noc2cc(Cl)ccc12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 14/20 0.76
RAB9A P51151 4/20 0.55
MEN1 O00255 3/20 0.55
NPC1 O15118 3/20 0.55
KMT2A Q03164 3/20 0.55
TDP1 Q9NUW8 1/20 0.55
KDM4E B2RXH2 3/20 0.55
MAPT P10636 3/20 0.55
GAA P10253 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.48
CYP1A2 P05177 1/20 0.48
NFKB1 P19838 1/20 0.48
CYP2C19 P33261 1/20 0.48
RECQL P46063 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2441850 0.79 HIF1A (0.76) HIF1ARAB9AMEN1NPC1KMT2A
SCHEMBL2441805 0.74 HIF1A (0.68) HIF1ARAB9AMEN1NPC1KMT2A
SCHEMBL2438808 0.72 HIF1A (0.65) HIF1ARAB9AMEN1NPC1KMT2A
SCHEMBL2438083 0.72 KDM4E (0.51) HIF1AMEN1KMT2AKDM4EMAPT
SCHEMBL2681024 0.72 NPC1 (1.00) RAB9AMEN1NPC1KMT2ATDP1
SCHEMBL21819051 0.72 ALDH1A1 (0.51) HIF1AKMT2ASMN1; SMN2
SCHEMBL12519692 0.71 NPC1 (1.00) RAB9AMEN1NPC1KMT2ATDP1
SCHEMBL11787549 0.70 ALDH1A1 (0.50) HIF1AKMT2AKDM4ECYP1A2
SCHEMBL15426975 0.70 SMN1; SMN2 (0.74) RAB9AMEN1NPC1KMT2AMAPT
SCHEMBL29024718 0.70 NPC1 (0.72) RAB9AMEN1NPC1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893589-B1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS GRUENENTHAL GMBH (DE) 2011-09-14 EP claimed
US-20080312301-A1 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof GRUENENTHAL GMBH (DE) 2008-12-18 US claimed
US-20080312301-A1 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof GRUENENTHAL GMBH (DE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312301-A1 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof HTR5A, NPY5R, GRM5 HIF1A 2528/4885RAB9A 1962/4885MEN1 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.